查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565022

全球核酸標籤市場

Nucleic Acid Labeling
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到2030年全球核酸標籤市場將達到48億美元

2023年全球核酸標籤市場預計為29億美元，預計到2030年將達48億美元，2023年至2030年複合年成長率為7.5%。核酸標記試劑是本報告分析的細分市場之一，複合年成長率為8.3%，預計到分析期結束時將達到24億美元。分析期間，核酸標記試劑套件領域的複合年成長率預計為 7.2%。

美國市場預估為7.975億美元，中國預期複合年成長率為6.9%

預計2023年美國核酸標記市場規模將達7.975億美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 7.371 億美元，2023-2030 年分析期間複合年成長率為 6.9%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 7.0% 和 6.1%。在歐洲，德國的複合年成長率預計約為 6.0%。

全球核酸標記市場－主要趨勢與促進因素總結

為什麼核酸標記在現代分子生物學中很重要？

核酸標記是分子生物學和生物技術中的重要過程，可在各種研究和診斷應用中對 DNA、RNA 和其他核酸進行檢測、視覺化和定量。標記可以是螢光、放射性標記或酵素標記，用於原位雜合反應、PCR、微陣列和定序等技術。這些標記技術對於研究基因表現、檢測基因突變和詳細了解分子交互作用至關重要。隨著基因組學和精準醫學研究的加速，核酸標記在臨床診斷和生命科學研究中變得越來越重要，其中準確性和靈敏度至關重要。

技術進步如何形塑核酸標記市場？

核酸標記技術的進步正在推動研究和臨床應用的成長。螢光標記和染料化學的創新提高了檢測技術的敏感度和特異性，從而實現更清晰、更準確的結果。新一代標記試劑套件和試劑也簡化了流程，減少了與傳統標記方法相關的時間和複雜性。此外，自動標記系統在大規模基因組和藥物研究等高通量環境中越來越受歡迎。這些進步提高了核酸標記過程的效率和擴充性，使實驗室更容易處理更大的樣本量和更複雜的實驗。

基因組學和診斷學的興起將如何影響核酸標記？

對基因組學和個人化醫療的日益關注正在對核酸標記市場產生重大影響。隨著基因序列測定和分子診斷對醫療保健至關重要，對準確、高效的核酸標記方法的需求不斷增加。在臨床診斷中，標記核酸對於檢測遺傳疾病、感染疾病和癌症至關重要，而準確性對於確定有效的治療方法至關重要。此外，次世代定序(NGS) 和基於 CRISPR 的基因編輯等高通量技術的發展增加了對先進標記技術的需求，這些技術可以支援遺傳物質的大規模和快速分析。這一趨勢也是由基因組學研究投資的增加和生物製藥創新的興起所推動的。

核酸標記市場的成長由多種因素推動

核酸標記市場的成長受到多種因素的推動，包括分子生物學技術的進步、基因組學應用的擴大以及對高精度診斷工具的需求不斷增加。隨著次世代定序（NGS）技術和個人化醫療的普及，對先進核酸標記方法的需求不斷增加。螢光和酵素標記的創新使研究和臨床環境中能夠更快、更準確地獲得結果。此外，自動化高通量標籤系統的採用正在增加，從而提高了實驗室工作流程的效率。對癌症診斷、遺傳疾病和傳染性病原體的研究不斷增加，進一步增加了對支持快速、靈敏的核酸檢測和分析的標記技術的需求。政府對基因組研究和醫療保健進步的資助也有助於市場擴張。

受訪企業範例（12家知名企業）

  • Agilent Technologies, Inc.
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Merck KgaA
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP13640

Global Nucleic Acid Labeling Market to Reach US$4.8 Billion by 2030

The global market for Nucleic Acid Labeling estimated at US$2.9 Billion in the year 2023, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Nucleic Acid Labeling Kits segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$797.5 Million While China is Forecast to Grow at 6.9% CAGR

The Nucleic Acid Labeling market in the U.S. is estimated at US$797.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$737.1 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.0% CAGR.

Global Nucleic Acid Labeling Market – Key Trends & Drivers Summarized

Why Is Nucleic Acid Labeling Important in Modern Molecular Biology?

Nucleic acid labeling is a crucial process in molecular biology and biotechnology, enabling the detection, visualization, and quantification of DNA, RNA, and other nucleic acids in various research and diagnostic applications. Labels can be fluorescent, radioactive, or enzymatic, and they are used in techniques such as in situ hybridization, PCR, microarrays, and sequencing. These labeling techniques are essential for studying gene expression, detecting genetic mutations, and understanding molecular interactions at a detailed level. As research in genomics and precision medicine accelerates, nucleic acid labeling is becoming increasingly critical in both clinical diagnostics and life sciences research, where accuracy and sensitivity are paramount.

How Are Technological Advancements Shaping the Nucleic Acid Labeling Market?

Technological advancements in nucleic acid labeling are driving growth in both research and clinical applications. Innovations in fluorescent labeling and dye chemistry are enhancing the sensitivity and specificity of detection techniques, allowing for clearer and more accurate results. Next-generation labeling kits and reagents are also simplifying the process, reducing the time and complexity involved in traditional labeling methods. Additionally, automated labeling systems are gaining popularity in high-throughput environments, such as large-scale genomic studies and pharmaceutical research. These advancements are improving the efficiency and scalability of nucleic acid labeling processes, making it easier for laboratories to handle larger sample volumes and more complex experiments.

What Impact Does the Rise of Genomics and Diagnostics Have on Nucleic Acid Labeling?

The increasing focus on genomics and personalized medicine is significantly influencing the nucleic acid labeling market. As genetic sequencing and molecular diagnostics become more integral to healthcare, the demand for accurate and efficient nucleic acid labeling methods is rising. In clinical diagnostics, labeled nucleic acids are essential for detecting genetic disorders, infectious diseases, and cancers, where precision is critical for effective treatment decisions. In addition, the growth of high-throughput technologies, such as next-generation sequencing (NGS) and CRISPR-based gene editing, is expanding the need for advanced labeling techniques that can support large-scale, rapid analysis of genetic material. This trend is also being driven by increasing investments in genomics research and the rise of biopharmaceutical innovations.

Growth in the Nucleic Acid Labeling Market Is Driven by Several Factors

Growth in the nucleic acid labeling market is driven by several factors, including advancements in molecular biology techniques, the expanding application of genomics, and the rising demand for high-precision diagnostic tools. The proliferation of next-generation sequencing (NGS) technologies and the growing use of personalized medicine are increasing the need for sophisticated nucleic acid labeling methods. Technological innovations in fluorescent and enzymatic labeling are enabling faster, more accurate results in both research and clinical settings. Additionally, the increasing adoption of automated and high-throughput labeling systems is enhancing workflow efficiency in laboratories. Growing research into cancer diagnostics, genetic diseases, and infectious pathogens is further fueling demand for labeling technologies that support rapid, sensitive nucleic acid detection and analysis. Government funding for genomics research and healthcare advancements is also contributing to the market’s expansion.

Select Competitors (Total 12 Featured) -

  • Agilent Technologies, Inc.
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Merck KgaA
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Nucleic Acid Labeling - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Molecular Diagnostics and Research Drives Growth in Nucleic Acid Labeling Applications
    • Advances in Fluorescent and Radioactive Labeling Technologies Expand Opportunities in DNA/RNA Labeling for Diagnostics
    • Rising Use of Nucleic Acid Labeling in Next-Generation Sequencing (NGS) and PCR Amplification Fuels Market Demand
    • Expanding Role of Genetic and Epigenetic Research Spurs the Adoption of Novel Nucleic Acid Labeling Methods
    • Growing Importance of Gene Expression Profiling Strengthens the Business Case for Labeling Techniques in Transcriptomics
    • Development of Cost-Effective and High-Sensitivity Labeling Kits Propels Growth in Clinical and Research Applications
    • Increasing Adoption of In-Situ Hybridization (ISH) Techniques Drives Demand for High-Precision Nucleic Acid Labeling
    • Growing Role of CRISPR-Based Research in Gene Editing Expands the Need for Advanced Nucleic Acid Labeling Technologies
    • Rising Focus on Personalized Medicine and Biomarker Discovery Spurs Market Demand for Innovative Labeling Solutions
    • Advances in Non-Radioactive Labeling Techniques Propel Growth in Safe and Environmentally Friendly Labeling Solutions
    • Rising Use of Labeling in Single-Cell Analysis Strengthens Demand for High-Specificity Nucleic Acid Labeling Kits
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nucleic Acid Labeling Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Nick Translation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Nick Translation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Random Primer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Random Primer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for In Vitro Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for In Vitro Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Reverse Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Reverse Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Labeling Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other Labeling Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World 7-Year Perspective for in Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 25: World 7-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World 7-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Fluorescence in Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World 7-Year Perspective for Fluorescence in Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 31: World 7-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Blotting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World 7-Year Perspective for Blotting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: USA 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: USA 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Canada 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Canada 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • JAPAN
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Japan 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Japan 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • CHINA
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: China 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: China 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • EUROPE
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 59: Europe 7-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Europe 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Europe 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • FRANCE
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 66: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: France 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 70: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: France 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • GERMANY
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: Germany 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 76: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: Germany 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • ITALY
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Italy 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 82: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Italy 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • UNITED KINGDOM
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 84: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: UK 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 88: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: UK 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 103: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 106: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 107: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030

IV. COMPETITION